AKAP8L anticorps
Aperçu rapide pour AKAP8L anticorps (ABIN7467916)
Antigène
Voir toutes AKAP8L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Specificité
- Knockdown/Knockout validation was supported by references (PMID:26990993)
-
Réactivité croisée
- Humain
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the center region of human AKAP8L. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:1000-1:10000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: 293T Validation: KO/KD
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- AKAP8L (A Kinase (PRKA) Anchor Protein 8-Like (AKAP8L))
-
Autre désignation
- A-kinase anchoring protein 8 like
-
Sujet
-
Synonyms: A-kinase anchoring protein 8 like , HA95 , HAP95 , NAKAP , NAKAP95
Background: Could play a role in constitutive transport element (CTE)-mediated gene expression. Does not seem to be implicated in the binding of regulatory subunit II of PKA. May be involved in nuclear envelope breakdown and chromatin condensation. May regulate the initiation phase of DNA replication when associated with TMPO-beta.
-
Poids moléculaire
- 72 kDa
-
ID gène
- 26993
-
UniProt
- Q9ULX6
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-